4//SEC Filing
Moran Kyle 4
Accession 0000950170-24-042381
CIK 0001631574other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 8:00 PM ET
Size
5.6 KB
Accession
0000950170-24-042381
Insider Transaction Report
Form 4
Moran Kyle
Chief Financial Officer
Transactions
- Sale
Ordinary Shares
2024-04-03$6.17/sh−15,630$96,421→ 33,921 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023.
- [F2]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $6.115 to $6.23 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]Includes 3,431 ordinary shares acquired on January 14, 2024, under the issuer's 2019 Employee Share Purchase Plan.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001657765
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 8:00 PM ET
- Size
- 5.6 KB